Streetbeat News

Stock Prices

AEHR

Aehr Test Systems (NASDAQ:AEHR) is scheduled to release its quarterly earnings report on January 9, 2024. Analysts predict an EPS of $0.19. Investors will be looking for an earnings beat and positive guidance for future growth. Historically, AEHR's stock price has shown volatility post-earnings, with both increases and decreases following past reports. Currently, AEHR shares are trading at $22.49, down 20.7% over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 3:00 pm

IBN

ICICI Bank (NYSE:IBN) has delivered an average annual return of 17.27% over the past 5 years, outperforming the market by 4.66% on an annualized basis. A $100 investment in IBN 5 years ago would be worth $219.77 today. The company's current market capitalization stands at $83.01 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 3:00 pm

CHX

ChampionX (NASDAQ:CHX) has been analyzed by 4 analysts, showing a mix of opinions with an average 12-month price target of $35.25, down from $39.50. All four analysts have lowered their price targets, with the highest at $39.00 and the lowest at $32.00. The company, which specializes in chemical solutions and equipment for oil and gas production, has seen a -8.01% decline in revenue growth and has a net margin of 8.27%. Its ROE is below industry average at 4.5%, but its ROA is strong at 2.34%, and it has a healthy debt-to-equity ratio of 0.39.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 3:00 pm

SAR

Saratoga Investment (NYSE:SAR) is scheduled to release its quarterly earnings report on January 9, 2024. Analysts predict an EPS of $1.03. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, SAR's stock price has been sensitive to earnings performance and guidance. Last quarter, SAR met the EPS estimate but saw a 2.15% decline in stock price the following day. Over the past year, SAR shares have decreased by 3.48%, trading at $26.35 as of January 5.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 3:00 pm

MATICUSD

Polygon's (CRYPTO: MATIC) price has decreased by 5.6% over the past 24 hours to $0.80, marking a continuation of a downward trend with a 19.0% drop over the past week. The trading volume for Polygon has increased by 18.0% over the same period, while the circulating supply rose by 0.27% to 9.28 billion, which is 92.83% of the max supply. Polygon's market cap is currently ranked #16 at $7.42 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 3:00 pm

SONY

Sony Group Corp (NYSE:SONY) is considering withdrawing from a merger deal with Zee Entertainment Enterprises Ltd due to disagreements over leadership roles. The initial agreement had Zee's CEO Punit Goenka leading the merged entity, but Sony has changed its stance amid Zee's regulatory issues. Sony plans to file a termination notice before the January 20 deadline, as certain conditions for the merger have not been met. Discussions are ongoing, and a resolution is possible before the deadline. Sony's stock saw a slight increase of 0.25% to $91.45.

Portfolio Pulse from Lekha Gupta

January 08, 2024 | 2:59 pm

FDUS

B. Riley Securities analyst Bryce Rowe has downgraded Fidus Investment (FDUS) from Buy to Neutral and set a price target of $22. This change reflects a revised outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:55 pm

ACON

Aclarion, Inc. (ACON) shares have risen following the announcement of a partnership agreement with Alphatec Spine, Inc. This partnership is expected to be beneficial for Aclarion as it may lead to increased exposure and potential revenue growth through collaboration with Alphatec Spine, a company specializing in the design and development of spinal surgery products.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:53 pm

MAIN

B. Riley Securities analyst Bryce Rowe has downgraded Main Street Capital (MAIN) from Buy to Neutral and set a price target of $47.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:51 pm

SLDB

Shares of Solid Biosciences (SLDB) were halted on a circuit breaker due to a sharp increase in price, with the stock surging 56.4%.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:49 pm